Archived weekly brief

Weekly NADAC Price Changes

A weekly executive brief covering the pricing movements that matter most to market strategy and reimbursement planning.

Week of August 12, 2026

Compared with August 5, 2026

Weekly NADAC pricing brief

Respiratory and cardiovascular names led a narrower repricing week as supplier-level changes remained concentrated rather than market-wide.

The prior release showed a more selective set of price resets, with supplier-specific moves driving most of the measured impact. Relief showed up in several established cardiovascular therapies, but broad deflation still did not develop across the full market.

Key takeaways

  • Respiratory products carried the highest concentration of meaningful weekly movement.
  • Manufacturer-level repricing stayed focused in a handful of portfolios rather than across multiple large suppliers.
  • Cardiovascular relief expanded, but the largest positive pressure remained elsewhere.

What to watch

Portfolio concentration

Whether the same manufacturers continue to account for the largest weighted changes next week.

Respiratory follow-through

Whether respiratory volatility persists or normalizes after a concentrated release.

Cardiovascular relief

Whether downward moves broaden into a more durable easing pattern.

Largest cost pressure

$10.6MUp

Largest absolute weekly price increase in the current release

Largest relief

$6.9MDown

Largest absolute weekly price decline in the current release

Most pressured class

Highest weighted movement this week

Largest manufacturer swing

Largest aggregate movement across tracked NDCs

Top 10 NDCs by weekly price movement

Up to 10 changed products are shown. Each edition preserves its published price comparison.

Notes and methodology

How the weekly brief calculations were ranked, aggregated, and preserved for archive consistency.

Top mover ranking

The Top 10 table ranks NDCs by absolute weekly impact: the change in unit price multiplied by dispensing exposure when available.

Segment summaries

Drug markets, manufacturers, and therapeutic classes aggregate the same NDC-level deltas. Average move is the mean percent change, while impact is the summed dollar-weighted effect using absolute price impact because dispensing-volume weighting was unavailable.

Headline cards and archive stability

Most pressured class selects the largest positive class impact, and largest manufacturer swing selects the manufacturer with the largest aggregate absolute impact. Every weekly brief stores a frozen snapshot so archived pages do not drift when live NADAC data changes.

More archived editions

Each edition is permanently archived under its release date.

Full archive

Explore the broader trend ecosystem